About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  QUARTERLY RESULTS
Quarterly Results      
Gland Pharma Ltd.
BSE Code 543245
ISIN Demat INE068V01023
Book Value 608.43
NSE Code GLAND
Dividend Yield % 0.91
Market Cap 327511.06
P/E 28.83
EPS 68.96
Face Value 1  
Quarters :
(Rs. in Millions)
Particulars (Rs in Million) Jun 2025Mar 2025Dec 2024Sep 2024
 Audited / UnAudited UnAudited UnAudited UnAudited UnAudited
Net Sales 10388.35 10303.53 10107.82 10629.90
Total Expenditure 6799.90 6362.30 6196.40 6991.90
PBIDT (Excl OI) 3588.45 3941.23 3911.42 3638.00
Other Income 547.41 437.18 650.64 578.03
Operating Profit 4135.86 4378.41 4562.06 4216.03
Interest 74.35 34.46 183.08 1.72
Exceptional Items 0 0 0 0
PBDT 4061.51 4343.95 4378.98 4214.31
Depreciation 437.68 430.72 437.67 416.15
Profit Before Tax 3623.83 3913.23 3941.31 3798.16
Tax 931.25 1013.24 990.08 981.06
Provisions and contingencies 0 0 0 0
Profit After Tax 2692.58 2899.99 2951.23 2817.10
Extraordinary Items 0 0 0 0
Prior Period Expenses 0 0 0 0
Other Adjustments 0.00 0.00 0.00 0.00
Net Profit 2692.58 2899.99 2951.23 2817.10
Equity Capital 164.76 164.76 164.75 164.75
Face Value (IN RS) 1 1 1 1
Reserves    
Calculated EPS 16.34 17.60 17.91 17.10
Calculated EPS (Annualised) 65.37 70.41 71.65 68.40
No of Public Share Holdings 79362489.00 79362489.00 79357789.00 79357789.00
% of Public Share Holdings 48.17 48.17 48.17 48.17
     
PBIDTM% (Excl OI) 34.54 38.25 38.70 34.22
PBIDTM% 39.81 42.49 45.13 39.66
PBDTM% 39.10 42.16 43.32 39.65
PBTM% 34.88 37.98 38.99 35.73
PATM% 25.92 28.15 29.20 26.50
 Notes Notes Notes Notes
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.